Aantal gebruikers naar leeftijd en geslacht voor ATC-subgroep B01A : Antithrombotica in 2022
- Raming voor de totale Zvw-populatie
| Mannen | Vrouwen | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0-4 | 5-14 | 15-24 | 25-44 | 45-64 | 65-74 | 75 + | 0-4 | 5-14 | 15-24 | 25-44 | 45-64 | 65-74 | 75 + | |
| B01AA Vitamine k-antagonisten | 21 | 86 | 224 | 2.276 | 18.810 | 27.935 | 57.459 | 17 | 50 | 220 | 2.493 | 12.941 | 14.511 | 48.219 |
| B01AB Heparinegroep | 67 | 188 | 4.158 | 8.843 | 21.436 | 17.644 | 14.088 | 54 | 155 | 4.300 | 18.126 | 28.222 | 21.820 | 22.156 |
| B01AC Trombocytenaggregatieremmers excl heparine | 228 | 473 | 729 | 9.625 | 195.130 | 228.590 | 251.060 | 148 | 349 | 1.524 | 25.769 | 113.050 | 139.940 | 228.880 |
| B01AD Enzymen | . | . | . | . | . | . | 1 | . | . | . | . | 1 | 1 | 1 |
| B01AE Directe trombineremmers | . | . | 15 | 259 | 4.600 | 11.047 | 19.078 | . | . | 38 | 242 | 2.411 | 6.082 | 16.397 |
| B01AF Directe remmers van factor xa | 18 | 38 | 574 | 5.383 | 50.279 | 78.115 | 116.640 | 14 | 33 | 831 | 5.607 | 30.816 | 50.820 | 115.280 |
| B01AX Overige antithrombotica | . | . | 44 | 226 | 599 | 315 | 207 | . | . | 41 | 414 | 774 | 376 | 394 |